Edward P. Feener is CSO at KalVista Pharmaceuticals, Inc. (KALV). They have made 16 open-market trades across 1 company since 2019, most recently 2024-05-20.
CIK 0001691090
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KALV | 72,858 | $2.0M |
Shares reported on the most recent Form 4, priced at the 2024-05-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KALV | SELL | 2024-05-20 | 2024-05-21 | $11.76 | $190K | +5.6% | -2.3% | +6.7% |
| KALV | SELL · 10b5-1 | 2024-02-20 | 2024-02-21 | $14.06 | $791K | +7.0% | -9.6% | -11.4% |
| KALV | SELL | 2024-02-14 | 2024-02-16 | $15.01 | $846K | -6.5% | -17.9% | -17.3% |
| KALV | SELL · 10b5-1 | 2024-01-11 | 2024-01-12 | $13.03 | $591K | -1.0% | +23.6% | -6.8% |
| KALV | SELL · 10b5-1 | 2024-01-08 | 2024-01-10 | $13.01 | $449K | -1.8% | +25.6% | -7.3% |
| KALV | SELL | 2023-11-20 | 2023-11-21 | $8.23 | $41K | +11.4% | +41.2% | +72.9% |
| KALV | SELL | 2023-08-18 | 2023-08-21 | $10.73 | $107K | -1.1% | -13.3% | -25.2% |
| KALV | SELL | 2023-05-18 | 2023-05-19 | $10.14 | $18K | -3.2% | -7.5% | +5.0% |
| KALV | SELL | 2023-02-17 | 2023-02-23 | $7.66 | $17K | -1.7% | -15.4% | +32.9% |
| KALV | SELL | 2022-11-18 | 2022-11-21 | $5.44 | $3K | +3.7% | +5.0% | +50.5% |
| KALV | SELL | 2022-08-17 | 2022-08-19 | $14.96 | $8K | +9.8% | +0.0% | -64.2% |
| KALV | SELL | 2021-11-01 | 2021-11-03 | $18.07 | $108K | -4.0% | -31.9% | -29.9% |
| KALV | SELL | 2021-08-02 | 2021-08-04 | $20.52 | $123K | -6.0% | +2.3% | -8.6% |
| KALV | SELL | 2021-06-01 | 2021-06-03 | $26.71 | $1.8M | +6.9% | -13.9% | -22.2% |
| KALV | SELL | 2021-05-03 | 2021-05-07 | $24.84 | $149K | +2.4% | +12.7% | -18.1% |
| KALV | SELL | 2021-02-23 | 2021-02-25 | $33.59 | $2.0M | -5.6% | -20.7% | -22.2% |
| KALV | SELL | 2020-11-02 | 2020-11-04 | $17.14 | $103K | +4.3% | +6.5% | -16.3% |
| KALV | SELL | 2020-10-20 | 2020-10-22 | $17.91 | $565K | +8.5% | +16.7% | +3.8% |
| KALV | SELL · 10b5-1 | 2020-10-16 | 2020-10-20 | $17.00 | $17K | -0.6% | +6.9% | -2.0% |
| KALV | SELL · 10b5-1 | 2020-02-05 | 2020-02-07 | $17.11 | $2K | -9.1% | -22.8% | -35.7% |
| KALV | SELL · 10b5-1 | 2019-07-22 | 2019-07-24 | $18.62 | $61K | -13.6% | -13.1% | -38.5% |
| KALV | SELL | 2019-04-17 | 2019-04-18 | $24.86 | $176K | -11.2% | -9.7% | -32.0% |
| KALV | SELL · 10b5-1 | 2019-01-16 | 2019-01-18 | $19.55 | $78K | +11.8% | +21.2% | +52.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.